True progress comes from medically guided decisions made with expertise and empathy, not commercial promises or overnight fixes
Ann Pediatr Endocrinol Metab
Pen-sharing poses a risk for transmission of blood-borne pathogens Hypoglycemia: Patients receiving Ozempic in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
Therapeutic inertia in intensification of insulin therapy should be avoided and, when clinicians are not familiar with multiple daily injection therapy, referral to specialist care and/or DSMES is warranted
These benefits appear to be driven by a combination of modest improvements in CV risk factors (e.g., weight loss, glycemia, blood pressure, lipids, and body weight) and direct vascular and antiinflammatory effects that stabilize plaques and reduce atherogenesis
Noom connects people to content, coaching, community, and clinicians to promote positive behavior and healthy habits, in an effort to promote healthspan and better living
